Calcium Vitamin Tablets launched; expansion into USD 16.29 Billion bone & joint health segment
Aayush Wellness has launched 'Aayush Calcium Vitamin Tablets', expanding its nutraceutical portfolio into the USD 16.29 Billion bone & joint health segment.
By ScoutQuest · · 2 min read
- Segment Size
- USD 16.29 Billion bone & joint health segment
- Category Size
- dietary supplements category at USD 178 billion
- Intimation Date
- October 16, 2026
The company has informed the exchanges about the launch of a new nutraceutical product, which adds to its existing portfolio.
What the intimation covers
- Aayush Wellness Limited has launched "Aayush Calcium Vitamin Tablets", described as a formulation aimed at everyday nutritional needs and at supporting bone and joint health.
- With this, the company expands its product portfolio into the bone and joint health segment, which the release sizes at USD 16.29 Billion.
- The release places the dietary supplements category at USD 178 billion, describing it as a high demand market driven by shifting consumer health priorities, rising nutritional gaps and a nationwide move toward proactive wellness solutions.
What is in the product
- The formulation includes Calcium Citrate, Vitamin D2, Magnesium, Zinc and Folic Acid.
- Calcium Citrate is described as being for superior absorption, paired with Vitamin D2 to enhance calcium utilisation and bone mineralisation.
- Magnesium and Zinc are said to further aid muscle function and joint support, while Folic Acid contributes to healthy cell renewal and metabolic balance.
Key benefits the release lists
- Helps improve calcium absorption and utilization
- Supports bone density and long-term skeletal strength
- Aids muscle function, joint mobility, and flexibility
- Addresses widespread nutrient deficiencies with a daily, easy-to-consume solution
The demand case quoted in the release
- India faces one of the world's highest rates of Vitamin D deficiency, affecting up to 80% to 90% of the population.
- Over 50% of Indian adults fail to meet daily calcium requirements, which the release links to the risk of weakened bones and musculoskeletal disorders.
- The dual deficiency of Vitamin and calcium is said to lead to muscle spasms, fatigue and increased joint problems.
- The release describes the affected group as a multi hundred million population opportunity.
Management comment
Kashiram Jadhav, Director, said India's nutrient insufficiencies make the entry into this category "timely and strategically aligned with real consumer needs". He described Aayush Calcium Vitamin Tablets as reflecting a commitment to proactive healthcare and scientific rigor, and called it a high-growth category that is central to India's long-term wellness transition and holds "strong commercial potential for our shareholders".
About the company, as stated
Aayush Wellness Limited is described as an integrated healthcare and preventive healthcare company established in 1984, with ISO 9000 and 22000 certification, offering wellness products and services.
How a reader can look at it
- This is an intimation of a product launch and a portfolio addition, along with the company's own assessment of the size of the category it is entering.
- The perception it can create is of portfolio expansion into a larger addressable category; how much of that converts into business would depend on how the product is received in the market.
More numbers
- Bone & joint health segment size cited in releaseUSD 16.29 Billion
- Dietary supplements category size cited in releaseUSD 178 billion
- Share of India's population affected by Vitamin D deficiency (as cited)80% to 90%
- Indian adults not meeting daily calcium requirements (as cited)Over 50%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.